APRE — Aprea Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1781983 ·
Last close
$0.45
Market Cap
$6.43M
52W High
$1.49
52W Low
$0.39
ADV30
204,764
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -5,173,529 -4,809,980 38,811,860 37,846,363 4,702,302
Jun 2026 0 — -4,032,180 -3,591,304 42,289,924 41,233,428 3,819,663
Mar 2026 0 — -3,430,412 -3,287,917 47,612,387 46,466,202 6,024,007
Dec 2025 0 — -2,643,093 -2,455,630 15,933,401 14,599,347 3,491,719

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-12,168,011
Investing CF
$0
Financing CF
$36,885,952
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.08
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-340,520,662
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-13,223,073
Pretax Income TTM
$-12,307,261
Interest Exp TTM
—
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,185
EBITDA
$-13,201,041
Free Cash Flow
$-8,151,741
Enterprise Value
$-34,145,024
Total Cash
$41,233,428
Total Debt
$0
Shares Out
14,191,136
Trailing EPS
$-0.95
Book Value
$1.52
ROE
-46.1%
ROA
-27.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -13,233,836 -12,599,569 15,933,401 3,491,719 12,441,682 -12,894,439
Dec 2024 0 -14,319,655 -12,958,711 23,979,493 4,672,038 19,307,455 -13,556,718
Dec 2023 0 -15,471,963 -14,286,756 22,650,174 5,696,668 16,953,506 -12,177,608
Dec 2022 0 -37,372,044 -112,662,027 30,155,827 4,512,149 25,643,678 -25,011,136

TTM Snapshot

Revenues TTM
$5,185
NetIncome TTM
$-12,307,261
OpCashFlow TTM
—
Assets (Latest)
$42,289,924
Forward EPS
$-0.40

Peers — same industry

TickerNameMarket CapLastDaily %
TOVX Theriva Biologics, Inc. $6.42M $0.14 —
TPST Tempest Therapeutics, Inc. $6.54M $0.33 —
ENVB Enveric Biosciences, Inc. $6.31M $1.41 —
CVKD Cadrenal Therapeutics, Inc. $6.71M $1.88 —
SNGX SOLIGENIX, INC. $6.11M $0.28 —

News headlines (Yahoo Finance, 1h cache)

Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
2026-11-05 21:05 · Yahoo
Aprea Therapeutics Announces Third Quarter 2026 Financial Results
2026-11-04 13:30 · Yahoo
Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology
2026-10-16 12:30 · Yahoo
Aprea Therapeutics to Present at October Conferences
2026-10-05 12:30 · Yahoo
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
2026-09-22 12:30 · Yahoo
Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
2026-09-10 12:00 · Yahoo
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
2026-08-28 12:15 · Yahoo
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
2026-08-12 12:30 · Yahoo
Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026
2026-07-30 12:00 · Yahoo
Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement
2026-04-01 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.